Natixis’s T2 Biosystems, Inc TTOO Stock Holding History

Natixis’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-107	Closed	-$491K	–	1384
2021 Q3	$491K	Buy	+107	New	+$539K	﹤0.01%	1018

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Natixis's TTOO Position: Q4 2021 in Review

Natixis sold out of T2 Biosystems, Inc (TTOO) in Q4 2021, closing a stake of 107 shares — an estimated $491K sold.

Natixis first reported a position in TTOO in Q3 2021 and held it in 1 quarter. The position peaked at $491K in Q3 2021. 70 funds tracked by Wall St. Rank hold TTOO as of Q4 2021.

Natixis reported no remaining T2 Biosystems, Inc position as of Q4 2021 after selling out during the quarter.
Natixis sold 107 T2 Biosystems, Inc shares in Q4 2021, an estimated $491K.
Natixis first reported a position in T2 Biosystems, Inc in Q3 2021 and held it in 1 quarter.
Natixis's T2 Biosystems, Inc position peaked at $491K in Q3 2021.
70 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q4 2021.

Based on Natixis's 13F filing for Q4 2021, filed 14 Feb 2022.